CO6551741A2 - Vacunas y diagnóstico contra la tripanosomosis - Google Patents

Vacunas y diagnóstico contra la tripanosomosis

Info

Publication number
CO6551741A2
CO6551741A2 CO12076206A CO12076206A CO6551741A2 CO 6551741 A2 CO6551741 A2 CO 6551741A2 CO 12076206 A CO12076206 A CO 12076206A CO 12076206 A CO12076206 A CO 12076206A CO 6551741 A2 CO6551741 A2 CO 6551741A2
Authority
CO
Colombia
Prior art keywords
vaccines
tripanosomosis
present
proteins
diagnosis against
Prior art date
Application number
CO12076206A
Other languages
English (en)
Inventor
Linares Virigine Coustou
Theo Baltz
Nicolas Plazolles
Original Assignee
Univ Bordeaux Segalen
Centre Nat Rech Scient
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Bordeaux Segalen, Centre Nat Rech Scient filed Critical Univ Bordeaux Segalen
Publication of CO6551741A2 publication Critical patent/CO6551741A2/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1048—Glycosyltransferases (2.4)
    • C12N9/1081—Glycosyltransferases (2.4) transferring other glycosyl groups (2.4.99)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y204/00—Glycosyltransferases (2.4)
    • C12Y204/99—Glycosyltransferases (2.4) transferring other glycosyl groups (2.4.99)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01018—Exo-alpha-sialidase (3.2.1.18), i.e. trans-sialidase

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

La presente invención tiene como objeto un material genético nuevo que codifica proteínas análogas de trans-sialidasa de tripanosomas africanos y se refiere al uso de dichos genes y proteínas en vacunas, tratamientos y diagnósticos. La presente invención también se refiere a la inmunización de seres humanos y/o animales no humanos contra la tripanosomosis.
CO12076206A 2009-11-10 2012-05-09 Vacunas y diagnóstico contra la tripanosomosis CO6551741A2 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0957953A FR2952382B1 (fr) 2009-11-10 2009-11-10 Vaccins et diagnostics contre les trypanosomoses animales africaines

Publications (1)

Publication Number Publication Date
CO6551741A2 true CO6551741A2 (es) 2012-10-31

Family

ID=42170832

Family Applications (2)

Application Number Title Priority Date Filing Date
CO12076211A CO6551742A2 (es) 2009-11-10 2012-05-09 Aplicaciones terapèuticas y de diagnóstico contra tripanosomosis
CO12076206A CO6551741A2 (es) 2009-11-10 2012-05-09 Vacunas y diagnóstico contra la tripanosomosis

Family Applications Before (1)

Application Number Title Priority Date Filing Date
CO12076211A CO6551742A2 (es) 2009-11-10 2012-05-09 Aplicaciones terapèuticas y de diagnóstico contra tripanosomosis

Country Status (12)

Country Link
US (1) US20120276131A1 (es)
EP (1) EP2499244A1 (es)
CN (1) CN102858963A (es)
AP (1) AP2012006303A0 (es)
AU (1) AU2010317992A1 (es)
BR (1) BR112012011009A2 (es)
CA (1) CA2779076A1 (es)
CO (2) CO6551742A2 (es)
FR (1) FR2952382B1 (es)
MX (1) MX2012005406A (es)
WO (1) WO2011058080A1 (es)
ZA (1) ZA201203412B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9744220B2 (en) 2013-03-14 2017-08-29 Tufts University Compositions and methods for treating inflammatory diseases
WO2014167112A1 (en) * 2013-04-12 2014-10-16 Danmarks Tekniske Universitet A mutant sialidase having trans-sialidase activity for use in production of sialylated glycans
CN103278642A (zh) * 2013-05-15 2013-09-04 广西大学 一种检测伊氏锥虫vsg抗原的双抗体夹心酶联免疫吸附测定试剂盒及制备方法
US10821164B2 (en) * 2015-06-23 2020-11-03 Saint Louis University Peptides for inducing Chagas disease responses
RU2686695C1 (ru) * 2017-11-27 2019-04-30 Федеральное государственное бюджетное научное учреждение "Всероссийский научно-исследовательский институт экспериментальной ветеринарии имени Я.Р. Коваленко" (ФГБНУ ВИЭВ) Способ дифференциальной диагностики случной болезни (t. equiperdum) и сурры (t. evansi) лошадей

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR958035A (es) 1950-03-02
US6027934A (en) * 1994-04-29 2000-02-22 Powell; Curtis Vaccine for, diagnostic assay for and method of treating parasitic hemoflagellate protozoa
TNSN97045A1 (fr) * 1996-03-12 2005-03-15 Sovarec Sa Histones de trypanosomatides, genes et derives de genes les codant, construction d'adn, vecteur, organismes hote, tests et vaccins correspondants, et leur utilisation.
AU8737701A (en) 2000-09-06 2002-03-22 Black, Samuel J. Purification, characterization and use of protective antigenic structures against trypanosomes and related parasites
DE10258400A1 (de) * 2002-12-13 2004-06-24 N.V. Nutricia Trans-Sialidasen aus Trypanosoma congolense
JP4553354B2 (ja) * 2004-10-04 2010-09-29 正隆 井原 抗トリパノソーマ剤
WO2007107488A2 (en) 2006-03-17 2007-09-27 Vib Vzw Vaccine against trypanosoma cruzi infection
WO2008134643A2 (en) 2007-04-28 2008-11-06 Fraunhofer Usa, Inc. Trypanosoma antigens, vaccine compositions, and related methods

Also Published As

Publication number Publication date
ZA201203412B (en) 2013-07-31
FR2952382A1 (fr) 2011-05-13
AU2010317992A1 (en) 2012-06-21
CN102858963A (zh) 2013-01-02
CA2779076A1 (en) 2011-05-19
AP2012006303A0 (en) 2012-06-30
WO2011058080A1 (fr) 2011-05-19
CO6551742A2 (es) 2012-10-31
BR112012011009A2 (pt) 2016-11-29
MX2012005406A (es) 2013-02-27
EP2499244A1 (fr) 2012-09-19
US20120276131A1 (en) 2012-11-01
FR2952382B1 (fr) 2011-11-25

Similar Documents

Publication Publication Date Title
CL2018000432A1 (es) Vacunas terapéuticas contra el hpv18
AR113340A2 (es) Secuencia reguladora de plantas
EP4273160A3 (en) Enhancing the effect of car-engineered t cells by means of nucleic acid vaccination
MX364714B (es) Animales no humanos geneticamente modificados y metodos de uso de los mismos.
CL2012001068A1 (es) Polinucleotido que codifica oleosina modificada incluyendo al menos una cisteina introducida artificialmente, constructo genetico que comprende dicho polinucleotido; célula huesped; composicion que comprende un cuerpo oleoso; alimento animal que comprende el cuerpo oleoso.
HK1142809A1 (en) Multimeric multiepitope influenza vaccines
CR11434A (es) Anticuerpos anti-amiloide humanos; composiciones, metodosy usos
CL2012000269A1 (es) Formulacion farmaceutica inyectable subcutanea altamente concentrada de un anticuerpo anti-her2 que comprende dicho anticuerpo, un amortiguador, un estabilizador, un tensioactivo no ionico y una enzima hialuronidasa; dispositivo de inyeccion; kit y uso de la formulacion para tratar enfermedades tales como cancer.
BRPI1014319A2 (pt) sistema para minimizar perda de circulação associada com a operação de um reservatório subterrâneo, e, método implementado por computador.
CL2013003132A1 (es) Composicion de alimento para animales y microbicida que comprende una cepa formadora de esporas de bacillus; y su uso para tratar o prevenir una enfermedad en un animal como septicemia enterica en animales acuaticos.
CO6551741A2 (es) Vacunas y diagnóstico contra la tripanosomosis
BR112012003884A2 (pt) Evento aad-1 das-40278-9, linhagens de milho trangênico relacionadas e identificação evento-específica das mesmas.
AU2009326524A8 (en) Use of Flt3 ligand for strengthening immune responses in RNA immunization
BR112015010911A2 (pt) Enzimas específicas de sítio e métodos de uso
BR112012032008A2 (pt) anticorpos s100a4 e usos terapêuticos do mesmo
DOP2012000187A (es) Antigeno ndv recombinante y usos del mismo
BR112014032636A2 (pt) Vacinas atenuadas de streptococcus suis e métodos de produção e usos das mesmas
AR080313A1 (es) Composiciones de virus de moquillo canino (cdv) recombinante y sus usos
AR090129A1 (es) Oligonucleotidos para la modulacion de la expresion genica y sus usos
CL2011002994A1 (es) Construccion de proteina que comprende polipeptido casb7439; composicion inmunogenica que comprende dicha construccion; uso de la composicion porque sirve para inducir respuesta inmunitaria al casb7439 en un animal.
IN2012DN01538A (es)
AR076727A1 (es) Metodo para proveer plantas fertiles por induccion de bbm durante transformacion
CL2012003219A1 (es) Parapoxvirus recombinante que comprende un parapoxvirus y adn heterólogo derivado de un virus de la rabia; procedimiento de preparación de dicho parapoxvirus; composicion inmunogénica; uso de la composicion para inducir respuesta inmunitaria contra el virus de la rabia en un animal.
AP2011005954A0 (en) Vaccine against African horse sickness virus.
CO6900115A2 (es) Polipéptido que tiene actividad inductora de la defensa contra estrés biótico en plantas, secuencia de nucleótidos que lo codifica, microorganismo, composiciones y métodos

Legal Events

Date Code Title Description
FC Application refused